Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-10 Aggarwal Sumit President and CEO Grant or award · Stock Option (Right to Buy) +328,833 328,833
2026-02-28 Aggarwal Sumit President and CEO Exercise or conversion +260,946 $0.15 $39K 1,672,756
2026-02-28 Aggarwal Sumit President and CEO Exercise or conversion · Stock Option (Right to Buy) −260,946 3,336,144
2026-01-24 Aggarwal Sumit President and CEO Exercise or conversion +15,000 1,411,810
2026-01-24 Aggarwal Sumit President and CEO Exercise or conversion · Restricted Stock Units −15,000 15,000
2025-09-19 Aggarwal Sumit President and CEO Grant or award +1,000,000 1,396,810
2025-09-19 Aggarwal Sumit President and CEO Grant or award · Stock Option (Right to Buy) +3,597,090 3,597,090
2025-08-14 Aggarwal Sumit President and CEO Exercise or conversion +196,880 $0.00 $20 396,810
2025-08-14 Aggarwal Sumit President and CEO Exercise or conversion · Stock Option (Right to Buy) −60,390 0
2025-08-14 Aggarwal Sumit President and CEO Exercise or conversion · Stock Option (Right to Buy) −68,700 0
2025-08-14 Aggarwal Sumit President and CEO Exercise or conversion · Stock Option (Right to Buy) −25,000 0
2025-08-14 Aggarwal Sumit President and CEO Exercise or conversion · Stock Option (Right to Buy) −42,790 0
2025-01-24 Aggarwal Sumit Director Exercise or conversion +30,000 199,930
2025-01-24 Aggarwal Sumit Director Exercise or conversion · Restricted Stock Units −30,000 30,000
2024-10-16 Aggarwal Sumit President and CEO Returned to the company · Stock Option (Right to Buy) −42,790 0
2024-10-16 Aggarwal Sumit President and CEO Grant or award · Stock Option (Right to Buy) +42,790 42,790
2024-10-16 Aggarwal Sumit President and CEO Returned to the company · Stock Option (Right to Buy) −35,580 0
2024-10-16 Aggarwal Sumit President and CEO Grant or award · Stock Option (Right to Buy) +35,580 35,580
2024-10-16 Aggarwal Sumit President and CEO Returned to the company · Stock Option (Right to Buy) −24,810 0
2024-10-16 Aggarwal Sumit President and CEO Grant or award · Stock Option (Right to Buy) +24,810 24,810

Page 1 of 2 · 33 trades